IE (Ireland) Core Implementation Guide
0.3.0 - draft Ireland flag

IE (Ireland) Core Implementation Guide - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

ValueSet: IE Core Vaccines

Official URL: https://hl7-ie.github.io/ie-core/fhir/ie/core/ValueSet/ie-core-vaccines Version: 0.3.0
Draft as of 2026-09-28 Computable Name: IECoreVaccines

Vaccine codes from the CDC CVX code system.

References

Logical Definition (CLD)

 

Expansion

Expansion from tx.fhir.org based on codesystem Vaccine Administered Code Set (CVX) version 20250715

This value set contains 287 concepts

SystemCodeDisplay (en)JSONXML
http://hl7.org/fhir/sid/cvx  01DTP
http://hl7.org/fhir/sid/cvx  02OPV, trivalent
http://hl7.org/fhir/sid/cvx  03MMR
http://hl7.org/fhir/sid/cvx  04M/R
http://hl7.org/fhir/sid/cvx  05measles
http://hl7.org/fhir/sid/cvx  06rubella
http://hl7.org/fhir/sid/cvx  07mumps
http://hl7.org/fhir/sid/cvx  08Hep B, adolescent or pediatric
http://hl7.org/fhir/sid/cvx  09Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
http://hl7.org/fhir/sid/cvx  10IPV
http://hl7.org/fhir/sid/cvx  11pertussis
http://hl7.org/fhir/sid/cvx  12diphtheria antitoxin
http://hl7.org/fhir/sid/cvx  13TIG
http://hl7.org/fhir/sid/cvx  14IG, unspecified formulation
http://hl7.org/fhir/sid/cvx  15influenza, split (incl. purified surface antigen)
http://hl7.org/fhir/sid/cvx  16influenza, whole
http://hl7.org/fhir/sid/cvx  17Hib, unspecified formulation
http://hl7.org/fhir/sid/cvx  18rabies, intramuscular injection
http://hl7.org/fhir/sid/cvx  19BCG
http://hl7.org/fhir/sid/cvx  20DTaP
http://hl7.org/fhir/sid/cvx  21varicella
http://hl7.org/fhir/sid/cvx  22DTP-Hib
http://hl7.org/fhir/sid/cvx  23plague
http://hl7.org/fhir/sid/cvx  24Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx  25typhoid, oral
http://hl7.org/fhir/sid/cvx  26cholera, unspecified formulation
http://hl7.org/fhir/sid/cvx  27botulinum antitoxin
http://hl7.org/fhir/sid/cvx  28DT (pediatric)
http://hl7.org/fhir/sid/cvx  29CMVIG
http://hl7.org/fhir/sid/cvx  30HBIG
http://hl7.org/fhir/sid/cvx  31Hep A, pediatric, unspecified formulation
http://hl7.org/fhir/sid/cvx  32meningococcal MPSV4
http://hl7.org/fhir/sid/cvx  33pneumococcal polysaccharide PPV23
http://hl7.org/fhir/sid/cvx  34RIG
http://hl7.org/fhir/sid/cvx  35tetanus toxoid, adsorbed
http://hl7.org/fhir/sid/cvx  36VZIG
http://hl7.org/fhir/sid/cvx  37yellow fever live
http://hl7.org/fhir/sid/cvx  38rubella/mumps
http://hl7.org/fhir/sid/cvx  39Japanese encephalitis SC
http://hl7.org/fhir/sid/cvx  40rabies, intradermal injection
http://hl7.org/fhir/sid/cvx  41typhoid, parenteral
http://hl7.org/fhir/sid/cvx  42Hep B, adolescent/high risk infant
http://hl7.org/fhir/sid/cvx  43Hep B, adult
http://hl7.org/fhir/sid/cvx  44Hep B, high-dosage, dialysis or IC
http://hl7.org/fhir/sid/cvx  45Hep B, unspecified formulation
http://hl7.org/fhir/sid/cvx  46Hib (PRP-D)
http://hl7.org/fhir/sid/cvx  47Hib (HbOC)
http://hl7.org/fhir/sid/cvx  48Hib (PRP-T)
http://hl7.org/fhir/sid/cvx  49Hib (PRP-OMP)
http://hl7.org/fhir/sid/cvx  50DTaP-Hib
http://hl7.org/fhir/sid/cvx  51Hib-Hep B
http://hl7.org/fhir/sid/cvx  52Hep A, adult
http://hl7.org/fhir/sid/cvx  53typhoid, parenteral, AKD (U.S. military)
http://hl7.org/fhir/sid/cvx  54adenovirus, type 4
http://hl7.org/fhir/sid/cvx  55adenovirus, type 7
http://hl7.org/fhir/sid/cvx  56dengue fever tetravalent
http://hl7.org/fhir/sid/cvx  57hantavirus
http://hl7.org/fhir/sid/cvx  58Hep C
http://hl7.org/fhir/sid/cvx  59Hep E
http://hl7.org/fhir/sid/cvx  60herpes simplex 2
http://hl7.org/fhir/sid/cvx  61HIV
http://hl7.org/fhir/sid/cvx  62HPV, quadrivalent
http://hl7.org/fhir/sid/cvx  63Junin virus
http://hl7.org/fhir/sid/cvx  64leishmaniasis
http://hl7.org/fhir/sid/cvx  65leprosy
http://hl7.org/fhir/sid/cvx  66Lyme disease
http://hl7.org/fhir/sid/cvx  67malaria
http://hl7.org/fhir/sid/cvx  68melanoma
http://hl7.org/fhir/sid/cvx  69parainfluenza-3
http://hl7.org/fhir/sid/cvx  70Q fever
http://hl7.org/fhir/sid/cvx  71RSV-IGIV
http://hl7.org/fhir/sid/cvx  72rheumatic fever
http://hl7.org/fhir/sid/cvx  73Rift Valley fever
http://hl7.org/fhir/sid/cvx  74rotavirus, tetravalent
http://hl7.org/fhir/sid/cvx  75Vaccinia (smallpox, mpox), live
http://hl7.org/fhir/sid/cvx  76Staphylococcus bacterio lysate
http://hl7.org/fhir/sid/cvx  77Tick-borne encephalitis vaccine (non-US)
http://hl7.org/fhir/sid/cvx  78tularemia vaccine
http://hl7.org/fhir/sid/cvx  79vaccinia immune globulin
http://hl7.org/fhir/sid/cvx  80VEE, live
http://hl7.org/fhir/sid/cvx  81VEE, inactivated
http://hl7.org/fhir/sid/cvx  82adenovirus, unspecified formulation
http://hl7.org/fhir/sid/cvx  83Hep A, ped/adol, 2 dose
http://hl7.org/fhir/sid/cvx  84Hep A, ped/adol, 3 dose
http://hl7.org/fhir/sid/cvx  85Hep A, unspecified formulation
http://hl7.org/fhir/sid/cvx  86IG
http://hl7.org/fhir/sid/cvx  87IGIV
http://hl7.org/fhir/sid/cvx  88influenza, unspecified formulation
http://hl7.org/fhir/sid/cvx  89polio, unspecified formulation
http://hl7.org/fhir/sid/cvx  90rabies, unspecified formulation
http://hl7.org/fhir/sid/cvx  91typhoid, unspecified formulation
http://hl7.org/fhir/sid/cvx  92VEE, unspecified formulation
http://hl7.org/fhir/sid/cvx  93RSV-MAb
http://hl7.org/fhir/sid/cvx  94MMRV
http://hl7.org/fhir/sid/cvx  95TST-OT tine test
http://hl7.org/fhir/sid/cvx  96TST-PPD intradermal
http://hl7.org/fhir/sid/cvx  97TST-PPD tine test
http://hl7.org/fhir/sid/cvx  98TST, unspecified formulation
http://hl7.org/fhir/sid/cvx  99RESERVED - do not use
http://hl7.org/fhir/sid/cvx  100pneumococcal conjugate PCV 7
http://hl7.org/fhir/sid/cvx  101typhoid, ViCPs
http://hl7.org/fhir/sid/cvx  102DTP-Hib-Hep B
http://hl7.org/fhir/sid/cvx  103meningococcal C conjugate
http://hl7.org/fhir/sid/cvx  104Hep A-Hep B
http://hl7.org/fhir/sid/cvx  105vaccinia (smallpox) diluted
http://hl7.org/fhir/sid/cvx  106DTaP, 5 pertussis antigens
http://hl7.org/fhir/sid/cvx  107DTaP, unspecified formulation
http://hl7.org/fhir/sid/cvx  108meningococcal ACWY, unspecified formulation
http://hl7.org/fhir/sid/cvx  109pneumococcal, unspecified formulation
http://hl7.org/fhir/sid/cvx  110DTaP-Hep B-IPV
http://hl7.org/fhir/sid/cvx  111Influenza, live, trivalent, intranasal, PF
http://hl7.org/fhir/sid/cvx  112tetanus toxoid, unspecified formulation
http://hl7.org/fhir/sid/cvx  113Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
http://hl7.org/fhir/sid/cvx  114meningococcal MCV4P
http://hl7.org/fhir/sid/cvx  115Tdap
http://hl7.org/fhir/sid/cvx  116rotavirus, pentavalent
http://hl7.org/fhir/sid/cvx  117VZIG (IND)
http://hl7.org/fhir/sid/cvx  118HPV, bivalent
http://hl7.org/fhir/sid/cvx  119rotavirus, monovalent
http://hl7.org/fhir/sid/cvx  120DTaP-Hib-IPV
http://hl7.org/fhir/sid/cvx  121zoster live
http://hl7.org/fhir/sid/cvx  122rotavirus, unspecified formulation
http://hl7.org/fhir/sid/cvx  123influenza, H5N1-1203
http://hl7.org/fhir/sid/cvx  125Novel Influenza-H1N1-09, nasal
http://hl7.org/fhir/sid/cvx  126Novel influenza-H1N1-09, preservative-free
http://hl7.org/fhir/sid/cvx  127Novel influenza-H1N1-09
http://hl7.org/fhir/sid/cvx  128Novel Influenza-H1N1-09, all formulations
http://hl7.org/fhir/sid/cvx  129Japanese Encephalitis, unspecified formulation
http://hl7.org/fhir/sid/cvx  130DTaP-IPV
http://hl7.org/fhir/sid/cvx  131typhus, historical
http://hl7.org/fhir/sid/cvx  132DTaP-IPV-HIB-HEP B, historical
http://hl7.org/fhir/sid/cvx  133Pneumococcal conjugate PCV 13
http://hl7.org/fhir/sid/cvx  134Japanese Encephalitis IM
http://hl7.org/fhir/sid/cvx  135Influenza, high-dose, trivalent, PF
http://hl7.org/fhir/sid/cvx  136Meningococcal MCV4O
http://hl7.org/fhir/sid/cvx  137HPV, unspecified formulation
http://hl7.org/fhir/sid/cvx  138Td (adult)
http://hl7.org/fhir/sid/cvx  139Td(adult) unspecified formulation
http://hl7.org/fhir/sid/cvx  140Influenza, split virus, trivalent, PF
http://hl7.org/fhir/sid/cvx  141Influenza, split virus, trivalent, preservative
http://hl7.org/fhir/sid/cvx  142tetanus toxoid, not adsorbed
http://hl7.org/fhir/sid/cvx  143Adenovirus types 4 and 7
http://hl7.org/fhir/sid/cvx  144influenza, seasonal, intradermal, preservative free
http://hl7.org/fhir/sid/cvx  145RSV-MAb (new)
http://hl7.org/fhir/sid/cvx  146DTaP,IPV,Hib,HepB
http://hl7.org/fhir/sid/cvx  147meningococcal MCV4, unspecified formulation
http://hl7.org/fhir/sid/cvx  148Meningococcal C/Y-HIB PRP
http://hl7.org/fhir/sid/cvx  149Influenza, live, quadrivalent, intranasal
http://hl7.org/fhir/sid/cvx  150Influenza, split virus, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  151influenza nasal, unspecified formulation
http://hl7.org/fhir/sid/cvx  152Pneumococcal Conjugate, unspecified formulation
http://hl7.org/fhir/sid/cvx  153Influenza, MDCK, trivalent, PF
http://hl7.org/fhir/sid/cvx  154Hep A, IG
http://hl7.org/fhir/sid/cvx  155Influenza, recombinant, trivalent, PF
http://hl7.org/fhir/sid/cvx  156Rho(D)-IG
http://hl7.org/fhir/sid/cvx  157Rho(D) -IG IM
http://hl7.org/fhir/sid/cvx  158Influenza, split virus, quadrivalent, preservative
http://hl7.org/fhir/sid/cvx  159Rho(D) - Unspecified formulation
http://hl7.org/fhir/sid/cvx  160Influenza A monovalent (H5N1), ADJUVANTED-2013
http://hl7.org/fhir/sid/cvx  161Influenza, injectable,quadrivalent, preservative free, pediatric
http://hl7.org/fhir/sid/cvx  162meningococcal B, recombinant
http://hl7.org/fhir/sid/cvx  163meningococcal B, OMV
http://hl7.org/fhir/sid/cvx  164meningococcal B, unspecified
http://hl7.org/fhir/sid/cvx  165HPV9
http://hl7.org/fhir/sid/cvx  166influenza, intradermal, quadrivalent, preservative free
http://hl7.org/fhir/sid/cvx  167meningococcal, unknown serogroups
http://hl7.org/fhir/sid/cvx  168Influenza, adjuvanted, trivalent, PF
http://hl7.org/fhir/sid/cvx  169Hep A, live attenuated
http://hl7.org/fhir/sid/cvx  170DTAP/IPV/HIB - non-US
http://hl7.org/fhir/sid/cvx  171Influenza, MDCK, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  172cholera, WC-rBS
http://hl7.org/fhir/sid/cvx  173cholera, BivWC
http://hl7.org/fhir/sid/cvx  174cholera, live attenuated
http://hl7.org/fhir/sid/cvx  175Rabies - IM Diploid cell culture
http://hl7.org/fhir/sid/cvx  176Rabies - IM fibroblast culture
http://hl7.org/fhir/sid/cvx  177PCV10
http://hl7.org/fhir/sid/cvx  178OPV bivalent
http://hl7.org/fhir/sid/cvx  179OPV ,monovalent, unspecified
http://hl7.org/fhir/sid/cvx  180tetanus immune globulin
http://hl7.org/fhir/sid/cvx  181anthrax immune globulin
http://hl7.org/fhir/sid/cvx  182OPV, Unspecified
http://hl7.org/fhir/sid/cvx  183Yellow fever vaccine live - alt
http://hl7.org/fhir/sid/cvx  184Yellow fever, unspecified
http://hl7.org/fhir/sid/cvx  185Influenza, recombinant, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  186Influenza, MDCK, quadrivalent, preservative
http://hl7.org/fhir/sid/cvx  187zoster recombinant
http://hl7.org/fhir/sid/cvx  188zoster, unspecified formulation
http://hl7.org/fhir/sid/cvx  189HepB-CpG
http://hl7.org/fhir/sid/cvx  190Typhoid conjugate vaccine (TCV)
http://hl7.org/fhir/sid/cvx  191meningococcal A polysaccharide (non-US)
http://hl7.org/fhir/sid/cvx  192meningococcal AC polysaccharide (non-US)
http://hl7.org/fhir/sid/cvx  193Hep A-Hep B, pediatric/adolescent
http://hl7.org/fhir/sid/cvx  194Influenza, Southern Hemisphere
http://hl7.org/fhir/sid/cvx  195DT, IPV adsorbed
http://hl7.org/fhir/sid/cvx  196Td, adsorbed, preservative free, adult use, Lf unspecified
http://hl7.org/fhir/sid/cvx  197Influenza, high-dose, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  198DTP-hepB-Hib Pentavalent Non-US
http://hl7.org/fhir/sid/cvx  200influenza, Southern Hemisphere, pediatric, preservative free
http://hl7.org/fhir/sid/cvx  201Influenza, Southern Hemisphere, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  202influenza, Southern Hemisphere, quadrivalent, with preservative
http://hl7.org/fhir/sid/cvx  203meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
http://hl7.org/fhir/sid/cvx  204Ebola Zaire vaccine, live, recombinant, 1mL dose
http://hl7.org/fhir/sid/cvx  205Influenza, adjuvanted, quadrivalent, PF
http://hl7.org/fhir/sid/cvx  206Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection
http://hl7.org/fhir/sid/cvx  207COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
http://hl7.org/fhir/sid/cvx  208COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx  210COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx  211COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx  212COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
http://hl7.org/fhir/sid/cvx  213SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
http://hl7.org/fhir/sid/cvx  214Ebola, unspecified
http://hl7.org/fhir/sid/cvx  215Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
http://hl7.org/fhir/sid/cvx  216Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
http://hl7.org/fhir/sid/cvx  217COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx  218COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx  219COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
http://hl7.org/fhir/sid/cvx  220HepB recombinant, 3-antigen, Al(OH)3
http://hl7.org/fhir/sid/cvx  221COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx  222Tick-borne encephalitis, unspecified
http://hl7.org/fhir/sid/cvx  223Tick-borne encephalitis, inactivated, PF, 0.25mL
http://hl7.org/fhir/sid/cvx  224Tick-borne encephalitis, inactivated, PF, 0.5mL
http://hl7.org/fhir/sid/cvx  225COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
http://hl7.org/fhir/sid/cvx  226COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
http://hl7.org/fhir/sid/cvx  227COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
http://hl7.org/fhir/sid/cvx  228COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx  229COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
http://hl7.org/fhir/sid/cvx  230COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
http://hl7.org/fhir/sid/cvx  231influenza, Southern Hemisphere, high-dose, quadrivalent
http://hl7.org/fhir/sid/cvx  300COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
http://hl7.org/fhir/sid/cvx  301COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
http://hl7.org/fhir/sid/cvx  302COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose
http://hl7.org/fhir/sid/cvx  303RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
http://hl7.org/fhir/sid/cvx  304Respiratory syncytial virus (RSV), unspecified
http://hl7.org/fhir/sid/cvx  305RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
http://hl7.org/fhir/sid/cvx  306RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
http://hl7.org/fhir/sid/cvx  307RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
http://hl7.org/fhir/sid/cvx  308COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx  309COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx  310COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
http://hl7.org/fhir/sid/cvx  311COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
http://hl7.org/fhir/sid/cvx  312COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
http://hl7.org/fhir/sid/cvx  313COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
http://hl7.org/fhir/sid/cvx  314Respiratory syncytial virus (RSV) vaccine, unspecified
http://hl7.org/fhir/sid/cvx  315Respiratory syncytial virus (RSV) MAB, unspecified
http://hl7.org/fhir/sid/cvx  316Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
http://hl7.org/fhir/sid/cvx  317Chikungunya live attenuated vaccine, 0.5 mL, PF
http://hl7.org/fhir/sid/cvx  318Anthrax, post-exposure prophylaxis
http://hl7.org/fhir/sid/cvx  319Anthrax vaccine, unspecified
http://hl7.org/fhir/sid/cvx  320Influenza, MDCK, trivalent, preservative
http://hl7.org/fhir/sid/cvx  321Influenza-avian, H5N8, monovalent, PF
http://hl7.org/fhir/sid/cvx  322Influenza-avian, H5N8, monovalent, preservative
http://hl7.org/fhir/sid/cvx  323Influenza-avian, H5, unspecified formulation
http://hl7.org/fhir/sid/cvx  324Poliovirus, inactivated, fractional-dose (fIPV)
http://hl7.org/fhir/sid/cvx  325Vaccinia (smallpox, mpox), unspecified
http://hl7.org/fhir/sid/cvx  326RSV, mRNA, injectable, PF
http://hl7.org/fhir/sid/cvx  327Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
http://hl7.org/fhir/sid/cvx  328Meningococcal oligosaccharide (MenACWY), (MenB), PF
http://hl7.org/fhir/sid/cvx  329Chikungunya, VLP, recombinant, 0.8 mL, PF
http://hl7.org/fhir/sid/cvx  330Dengue fever, unspecified
http://hl7.org/fhir/sid/cvx  331Influenza, Southern Hemisphere, trivalent, PF
http://hl7.org/fhir/sid/cvx  332RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
http://hl7.org/fhir/sid/cvx  333Influenza, live, trivalent, intranasal, self/caregiver admin, PF
http://hl7.org/fhir/sid/cvx  500COVID-19 Non-US Vaccine, Product Unknown
http://hl7.org/fhir/sid/cvx  501COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
http://hl7.org/fhir/sid/cvx  502COVID-19 IV Non-US Vaccine (COVAXIN)
http://hl7.org/fhir/sid/cvx  503COVID-19 LAV Non-US Vaccine (COVIVAC)
http://hl7.org/fhir/sid/cvx  504COVID-19 VVnr Non-US Vaccine (Sputnik Light)
http://hl7.org/fhir/sid/cvx  505COVID-19 VVnr Non-US Vaccine (Sputnik V)
http://hl7.org/fhir/sid/cvx  506COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
http://hl7.org/fhir/sid/cvx  507COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
http://hl7.org/fhir/sid/cvx  508COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
http://hl7.org/fhir/sid/cvx  509COVID-19 PS Non-US Vaccine (EpiVacCorona)
http://hl7.org/fhir/sid/cvx  510COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
http://hl7.org/fhir/sid/cvx  511COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
http://hl7.org/fhir/sid/cvx  512SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
http://hl7.org/fhir/sid/cvx  513SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
http://hl7.org/fhir/sid/cvx  514SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
http://hl7.org/fhir/sid/cvx  515SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
http://hl7.org/fhir/sid/cvx  516COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
http://hl7.org/fhir/sid/cvx  517SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
http://hl7.org/fhir/sid/cvx  518COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
http://hl7.org/fhir/sid/cvx  519COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
http://hl7.org/fhir/sid/cvx  520COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
http://hl7.org/fhir/sid/cvx  521COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
http://hl7.org/fhir/sid/cvx  801AS03 Adjuvant
http://hl7.org/fhir/sid/cvx  998no vaccine administered
http://hl7.org/fhir/sid/cvx  999unknown

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code